BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer.

被引：0
|
作者：
Bridgewater, J. A.
Stubbs, C.
Primrose, J. N.
机构：
[1] UCL, London, England
[2] Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England
[3] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4126
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.
    Primrose, John Neil
    Fox, Richard
    Palmer, Daniel H.
    Prasad, Raj
    Mirza, Darius
    Anthoney, David Alan
    Corrie, Philippa
    Falk, Stephen
    Wasan, Harpreet Singh
    Ross, Paul J.
    Wall, Lucy R.
    Wadsley, Jonathan
    Evans, T. R. Jeffry
    Stocken, Deborah
    Praseedom, Raaj
    Cunningham, David
    Garden, O. James
    Stubbs, Clive
    Valle, Juan W.
    Bridgewater, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care
    Rizzo, Alessandro
    Brandi, Giovanni
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (05) : 483 - 485
  • [3] BILCAP-study: Should patients with resected biliary tract cancer really receive adjuvant chemotherapy with capecitabine?
    Manzini, G.
    Klotz, U.
    Hines, I.
    Henne-Bruns, D.
    Kremer, M.
    Kirchner, M.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [4] Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical Trial
    Kulig, J.
    Kolodziejczyk, P.
    Sierzega, M.
    Bobrzynski, L.
    Jedrys, J.
    Popiela, T.
    Dadan, J.
    Drews, M.
    Jeziorski, A.
    Krawczyk, M.
    Starzynska, T.
    Wallner, G.
    ONCOLOGY, 2010, 78 (01) : 54 - 61
  • [5] Effect of Adjuvant Chemotherapy with S-1 or Uracil-Tegafur compared to Surgery Alone for Patients Undergoing Curative Resection of Biliary Tract Cancer
    Itano, O.
    Shinoda, M.
    Kitago, M.
    Abe, Y.
    Hibi, T.
    Yagi, H.
    Ishii, M.
    Kitagawa, Y.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S105 - S105
  • [6] A randomized, multi-center phase III trial of adjuvant chemotherapy with gemcitabine and capecitabine (GemCap) compared to capecitabine (Cap) alone in curatively resected biliary tract cancer (BilGemCap Study): KCSG HB20-14.
    Park, Joon Oh
    Park, Joon Seong
    Lee, Choong-kun
    Chon, Hong Jae
    Choi, Sae Byeol
    Hwang, Dae Wook
    Oh, Do-Youn
    Lee, Myung Ah
    Jang, Jin-Young
    Ryoo, Baek-Yeol
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS633 - TPS633
  • [7] Clinical results of intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of biliary tract cancer
    Hayashibe, A.
    Kameyama, M.
    HPB, 2008, 10 (02) : 144 - 147
  • [8] Effects of gene expression in 5-FU metabolic pathways in a phase III trial evaluating adjuvant S-1 therapy compared to surgery alone following curative resection for biliary tract cancer (JCOG1202A1).
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    Nomura, Shogo
    Morizane, Chigusa
    Todaka, Akiko
    Kamei, Keiko
    Yanagibashi, Hiroo
    Mizuno, Nobumasa
    Gotoh, Kunihito
    Kawamoto, Yasuyuki
    Shirakawa, Hirofumi
    Okano, Naohiro
    Nomura, Tatsuya
    Takahashi, Amane
    Makino, Isamu
    Anbo, Yoshiyasu
    Ohta, Koji
    Katayama, Hiroshi
    Konishi, Masaru
    Ueno, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 732 - 732
  • [9] Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines Versus Surgery-alone for Gastric Cancer
    Moon, Jeong Ho
    Fujiwara, Yoshiyuki
    Hirao, Motohiro
    Imamura, Hiroshi
    Kimura, Yutaka
    Fujitani, Kazumasa
    Fujita, Junya
    Tamura, Shigeyuki
    Takiguchi, Shuji
    Yano, Masahiko
    Mori, Masaki
    Doki, Yuichiro
    ANTICANCER RESEARCH, 2017, 37 (06) : 3061 - 3067
  • [10] A randomized phase III trial comparing adjuvant chemotherapy with S-1 vs. surgery alone in patients with resectable biliary tract cancer (JCOG1202: ASCOT).
    Ikeda, Masafumi
    Nakachi, Kohei
    Konishi, Masaru
    Mitsunaga, Shuichi
    Mizusawa, Junki
    Uesaka, Katsuhiko
    Saiura, Akio
    Yanagimoto, Hiroaki
    Morinaga, Soichiro
    Eba, Junko
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Ishii, Hiroshi
    Okusaka, Takuji
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345